Get in Touch
We love to help & we love to listen. Please fill out the form
below and we’ll get back to you within a day
As Donald Trump prepares for his historic second inauguration next week, excitement is palpable not only among his supporters but also within the cryptocurrency community.
The market has been brimming with optimism, as reports have indicated that the president-elect would announce several measures to help the digital asset industry expand.
Naturally, speculation around market moves has been running high, especially for heavyweights like Bitcoin (CRYPTO: BTC).
Several analysts that Benzinga spoke to provided interesting viewpoints about what to expect come Jan. 20.
According to Arthur Azizov, CEO of cryptocurrency payment company B2BINPAY, a “gradual” increase over Trump’s four-year term was a more plausible scenario than an "immediate" 100% spike for all coins.
Azizov predicted that Bitcoin would consolidate following the inauguration, giving altcoins room to rally.
"As for Bitcoin's price, I believe it could be around $100,000–$102,000 next month," Azizov added.
See Also: Litecoin Surges 12% After Analyst Says Altcoin Most Likely To Have Next ETF After Bitcoin, Ethereum
Chris Kline, COO and Co-Founder of BitcoinIRA, was confident that if the anticipated cryptocurrency-friendly executive orders are enacted, they would encourage blockchain innovation and digital asset usage.
Among the proposals being evaluated for inclusion in the executive order is the establishment of a national Bitcoin reserve that would include the government's current Bitcoin holdings. Such a move could have far-reaching implications for Bitcoin's future valuations.
With these factors at play, Kline expressed confidence that bold projections, including the $250,000 per Bitcoin target by Wall Street Strategist Tom Lee, seem probable.
Joe McCann, founder and CEO of cryptocurrency hedge fund Asymmetric, added to the positive outlook, saying, “The worst is behind us.”
McCann stated that Bitcoin reclaiming the key psychological barrier of $100,000 was indicative of a positive sentiment.
"Although it's trading slightly below that right now, it shows significant open interest with targets ranging from $125,000 to $150,000. This indicates bullish sentiment and expectations for continued price growth," he added.
Meanwhile, Arthur Hayes, co-founder of cryptocurrency exchange BitMEX, took a contrarian position, even forecasting a correction from present levels.
"I think Bitcoin will be range-bound between $90,000 and $100,000 until some of Trump's economic policies are clarified and the rest of the world reacts," Hayes told Benzinga.
Never before had the cryptocurrency community anticipated a presidential inauguration like this. While the true extent of the impact could not be accurately ascertained, there was little doubt that Trump's policies, or lack thereof, would dictate how the market moves in the near future.
Price Action: At the time of writing, Bitcoin was exchanging hands at $101,394.39, up 2.03% in the last 24 hours, according to data from Benzinga Pro.
Image via Shutterstock
Read Next:
The cryptocurrency sector is optimistic of what is to come with Donald Trump serving as the next president. Optimism comes as many cryptocurrencies have hit all-time highs since Trump won the 2024 presidential election.
A new Benzinga reader poll predicts which cryptocurrency could have the best return early in Trump's presidency.
What Happened: Trump will be sworn in as the next president of the United States on Monday, marking his second non-consecutive term as the leader of the country.
The stock market will be closed on Monday in honor of Martin Luther King Jr. Day, which is a federal holiday.
While investors won't be able to buy and sell stocks that could be mentioned individually or part of sectors that are highlighted during Trump's inauguration speech, the cryptocurrency market will be open.
"Which crypto will pump the most on Donald Trump's Inauguration Day?" Benzinga recently asked readers.
Here were the results:
The winner of the poll was XRP Token, which is one of the top gaining cryptocurrencies over the last year. XRP, which is from Ripple Labs, has been in the spotlight a lot recently, including thanks to a visit by Ripple executives to meet with Trump.
The poll saw only 7% of readers predict that cryptocurrency would crash on Monday, which could end up being the result of sell the news as cryptos trade higher ahead of Monday.
If Trump announces cryptocurrency related initiatives on Monday, the sector could see strength, but likewise cryptos could fall if he minimizes the sector in his speech.
Why It's Important: Benzinga readers have selected XRP and Bitcoin as winners in several polls, which won't make the latest results a huge surprise.
An early December 2024 poll asked Benzinga readers if any of several hand-picked cryptocurrencies would outperform XRP in 2025.
The results were:
Bitcoin won the poll with 28% of readers believing the leading cryptocurrency will outperform the other options in 2025.
Ranking second in the poll was None of the Above, which means 24% of readers think XRP will outperform the other six cryptocurrencies including Bitcoin in 2025.
Here are the current returns of the cryptocurrencies in the new poll:
XRP and Dogecoin have already had huge one-year gains and XRP is up significantly over the last month, which could make any additional gains on Monday icing on the cake as more eyes are on the cryptocurrency sector in 2025.
Read Next:
The study was conducted by Benzinga from Jan. 16, 2025 through Jan. 17, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 107 adults.
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Here's a look at the Benzinga Stock Whisper Index for the week ending Jan. 17:
Applovin Corporation (NASDAQ:APP): The mobile app technology company was one of the top-performing stocks in 2024 with shares up over 700%. The stock is following up the strong year with a surge in the early days of 2025 and momentum led by several analyst ratings in January. Wells Fargo maintained an Overweight rating and raised the price target from $360 to $366. Benchmark initiated coverage on the stock with a Buy rating and $375 price target. JPMorgan maintained a Neutral rating and raised the price target from $200 to $325. Jefferies maintained a Buy rating and raised the price target from $400 to $425. The company will report fourth-quarter financial results on Feb. 12, which could be an early indictor of how investors feel about the company's future growth. Analysts expect earnings per share to hit $1.24, up from $0.49 in last year's fourth quarter and revenue to hit $1.26 billion, up from $953.2 million in last year's fourth quarter. The company has beaten analyst estimates for earnings per share in six straight quarters and revenue estimates in seven of the last eight quarters.
The stock was up nearly 10% over the last five days, as shown on the Benzinga Pro chart below.
Quantum Computing Inc (NASDAQ:QUBT): One of the hottest sectors in 2024 and early 2025 for investors has been quantum computing. After a strong performance in 2024, Quantum Computing Inc saw shares fall on comments from NVIDIA CEO Jensen Huang and a short report. The Capybara Research alleges Quantum Computing is using misleading press releases that exaggerate the company's businesses.
"Quantum Deception. QUBT Is a rampant fraud. We are short and think shareholders will be left with nothing when all is done," Capybara Research said.
Huang sent shares of stocks in the sector lower recently when he said that quantum computing applications could be 20 years away. Nvidia later announced its first-ever quantum computing day and a Microsoft executive shared positive commentary on businesses preparing to be "quantum ready" by 2025.
In a recent Benzinga reader poll, Quantum Computing ranked second among four stocks in the sector that investors would most want to buy for 2025 with 24% of the vote. Beating Quantum Computing was Rigetti Computing Inc. with 33% of the vote.
Coinbase Global (NASDAQ:COIN): Interest in Coinbase is surging over the last week and it could be related to company announcements and the pending inauguration of President-elect Donald Trump on Jan. 20. Coinbase announced new Bitcoin (CRYPTO: BTC) loans where users can borrow up to $100,000 USDC (CRYPTO: USDC) and access cash without having to sell their cryptocurrency. Coinbase and other cryptocurrency-related companies could benefit from the new White House administration with Trump indicating that he could make Bitcoin a national priority and create a strategic reserve. The price of Bitcoin is trading higher ahead of Trump's inauguration and Coinbase shares are up over 20% in the last five days.
Sprouts Farmers Market (NASDAQ:SFM): The specialty grocery retailer returns to the Stock Market Index after an appearance back in November. The company, which has over 400 stores in 23 states, will report fourth-quarter financial results likely in February. Analysts expect the company to show earnings per share and revenue growth on a year-over-year basis. The company has beaten analyst estimates for both earnings per share and revenue in three straight quarters. Investors may be looking to the specialty retailer as Robert F. Kennedy Jr. could become the next leader of the Department of Health and Human Services under Trump's administration. Kennedy could push for healthier food options for consumers, which could benefit retailers specializing in healthy food options like Sprouts.
Comcast Corporation (NASDAQ:CMCSA): The media company saw strong interest from readers during the week, which comes as the company has some good news and could also be on watch as an enemy of Trump. Comcast broadcast one of the opening round games of the 2024 NFL Playoffs with the match between the Washington Commanders and Tampa Bay Buccaneers having an average of 29 million viewers. Comcast will also air the second-round matchup of the Los Angeles Rams and Philadelphia Eagles on Sunday, Jan. 19 at 3 p.m. ET. Comcast and its stock could also be drawing attention with the death of net neutrality, which could benefit the company.
Comcast also caught the attention of Trump recently with the incoming president threatening the company after late-night talk show host Seth Meyers criticized him.
"Comcast should pay a BIG price," Trump said, as reported by Deadline.
Trump blasted Comcast previously and threatened to pull their FCC license. Trump's appointee to lead the FCC is Brendan Carr, who is considering challenging networks like Comcast's NBC for featuring Kamala Harris in a "Saturday Night Live" episode and not providing equal time to Trump.
Stay tuned for next week’s report, and follow Benzinga Pro for all the latest headlines and top market-moving stories here.
Read the latest Stock Whisper Index reports here:
Read Next:
The S&P 500 Index and many stocks saw gains during Donald Trump's first term in the White House from 2017 to 2021. A new reader poll predicts how high the S&P 500 will go in Trump's next four years in office as he heads back to the White House on Monday, Jan. 20.
What Happened: Investors are weighing the impact of potential tariffs proposed by Trump that could happen under his next presidential term.
The last time Trump was in office, stock markets saw strong returns, including a strong first-year performance for many stock market indices.
The SPDR S&P 500 ETF Trust (NYSE:SPY), which tracks the S&P 500, was up 70% during Trump's first term in the White House.
Benzinga recently asked if the returns for his next four-year term would be similar.
"What do you think the return will be from 2025 through 2029?”
The results were:
The winning vote getter was a range of 31% to 45%. This would equate to an average of around 7.8% to 11.3% annually. The S&P 500 has an average annual return of around 10%, meaning readers see the index having average returns during Trump's upcoming time in the White House.
Did You Know?
Why It's Important: Trump famously predicted there would be an economic downturn and the stock market would crash if he did not win the 2020 presidential election.
While the economy saw turbulent times that had high inflation and worries for consumers during parts of President Joe Biden's time in the White House, stock market indices also hit all-time highs.
The Dow Jones and S&P 500 each hit highs while Biden was in office, leading to the president clapping back at Trump's earlier prediction.
"Good one, Donald," Biden wrote in a post on X, sharing a campaign video that highlighted the stock market's record highs.
The SPDR S&P 500 ETF is up 64.6% from Jan. 20, 2021 through Jan. 17, 2025 based on a price of $596.80 at the time of writing, making the return under Biden nearly the same as during Trump's first four years.
Here's a look at the returns by year for times when Biden and Trump were in office, with Biden inaugurated in 2021 and Trump inaugurated in 2017:
Along with anticipating how the stock market will do during Trump's next four years in the White House, Benzinga recently asked, "What do you think the return will be in 2025, his first year back?"
The results were:
The poll found the largest percentage believe the S&P 500 Index will post gains of at least 16% in 2025. The 11% to 15% range came in second place at 22%.
It’s also worth pointing out that the S&P 500 decline in 2025 was actually tied for second in the poll at 22%, which could mean 2025 is a make-or-break year.
Read Next:
The study was conducted by Benzinga from Jan. 14, 2025 through Jan. 15, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 107 adults.
Image: Shutterstock
The S&P 500 Index and many stocks saw gains after Donald Trump won the 2024 presidential election. A new reader poll predicts how high the S&P 500 will go in 2025 with Trump set to retake office on Jan. 20.
What Happened: Investors are bracing for a volatile 2025 with a new White House administration taking the helm, but optimism remains high that the stock market could see similar gains as compared to 2017.
In 2017, the SPDR S&P 500 ETF Trust (NYSE:SPY), which tracks the S&P 500 Index, was up 21.7%.
This was the first year with Trump in office and many sectors saw gains during the year.
Benzinga recently asked if history will repeat itself.
"What do you think the return will be in 2025, his first year back," Benzinga asked.
The results were:
The poll found the largest percentage believe the S&P 500 Index will post gains of at least 16% in 2025. The 11% to 15% range came in second place at 22%.
It's also worth pointing out that the S&P 500 decline in 2025 was actually tied for second in the poll at 22%, which could mean 2025 is a make-or-break year.
Did You Know?
Why It's Important: Stocks posted gains after Trump's win and many well-known and retail investor favorite stocks like Tesla hit all-time highs. Many of the most valuable companies have hit all-time highs since the election.
While there is optimism for strong market returns in 2025, there are also concerns that promises to place tariffs on China, Canada and Mexico could send costs higher on items for consumers. This could trigger higher prices and lower profits for companies in several industries.
Time will tell how the stock market performs under Trump's second time in the White House. This poll shows that many Benzinga readers are bullish on the potential for at least Trump's first year in office this time around.
Read Next:
The study was conducted by Benzinga from Jan. 14, 2025 through Jan. 15, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 128 adults.
Photo: Shutterstock
"I worked on a project called MOXIE, which is currently on Mars producing oxygen from its atmosphere," says Nohtal Partansky, founder of Sorting Robotics. It's a statement that feels plucked from a sci-fi movie, but it's the prelude to a career shift that's redefining cannabis manufacturing.
Armed with a degree in aerospace engineering and a stint at NASA's Jet Propulsion Laboratory (JPL), Partansky initially seemed destined to remain among the stars. However, his drive to solve real-world problems brought him back to Earth. In 2018, he and his co-founder launched Sorting Robotics with just $6,000 in seed money. The company initially focused on developing automation technologies for other industries, testing the waters of robotics in various sectors.
In 2020, a hands-on foray into the cannabis industry changed everything. "I co-founded a co-packing company with friends, managing 30 trimmers and packaging flower for California brands. That experience taught me what operators truly need," he said. Observing the inefficiencies of manual processes, Partansky saw an opportunity to transform cannabis manufacturing with robotics.
Out of this pivot came two groundbreaking machines: the Jiko Robot and the Stardust system. "The Jiko Robot is designed for live resin-infused joints," Partansky told Benzinga. By automating the precise injection of concentrates into pre-rolls, the machine ensures uniformity and scalability—essential for cannabis operators looking to meet growing consumer demand. Meanwhile, the Stardust system addressed the labor-intensive task of kief-coating pre-rolls, a product category popularized by brands like Jeeter.
Priced at $75,000 for the Jiko Robot and $240,000 for the Stardust system, these machines are an investment that quickly pays off. "Almost all of our customers see a return on investment within a year," says Partansky. The quick ROI stems from the automation of time-consuming tasks, allowing operators to scale their production without adding significant labor costs.
"The principles are the same," Partansky says, reflecting on his NASA experience. "Whether it's a robot on Mars or one in a cannabis facility, the focus is on precision, scalability and problem-solving." This engineering expertise, combined with a deep understanding of cannabis operations, has made Sorting Robotics a pivotal player in the industry.
Sorting Robotics didn't merely enter the cannabis space, it reshaped it with machines that solve labor-intensive challenges while delivering unmatched precision. Designed for live resin-infused and kief-coated pre-rolls, the Jiko Robot and Stardust system have become indispensable tools for manufacturers aiming to scale their operations.
"Before the Jiko Robot, the infusion process was entirely manual," says Partansky. "Operators couldn't scale efficiently, and product consistency was a constant challenge." By automating this intricate task, the Jiko Robot allows producers to create cold-infused joints—popularly known as “donut” joints or “donut holes”—with ease and consistency.
The Stardust system similarly tackles a common bottleneck. "Joints coated in cannabis concentrates are incredibly popular," Partansky explains. "Brands like Jeeter rely on them, but manual production limits scalability. Our Stardust system changes that by automating the coating process with robotic arms." This innovation eliminates variability, ensuring consistent quality while reducing labor costs.
While the engineering behind these systems is complex, their economic advantages are straightforward. "A $100,000 machine may seem costly," Partansky acknowledges, "but it's less than the annual salary of a couple of employees. And a machine doesn't get tired, make mistakes or take breaks." Automation also provides manufacturers with the reliability needed to compete in an increasingly saturated market.
Sorting Robotics' systems are scalable, appealing to a wide range of operators. "Our Jiko Robot baseline is around 20,000 joints a month," Partansky notes. "That's about 10 pounds of flower per week—not an unrealistic figure even for smaller operators." Whether a business is a boutique grower or a multi-state operator, automation simplifies expansion and minimizes labor dependency.
Interest in Sorting Robotics' systems extends beyond North America, with inquiries coming from countries like Germany. However, regulatory instability in emerging markets remains a hurdle. "Operators in international markets are cautious because the regulations aren't stable yet," Partansky explains. "Once these markets mature, the demand for automation will explode."
Partansky emphasizes that customer collaboration has been crucial to the company's success. "We work closely with our customers to refine our systems. Their feedback is invaluable in helping us innovate." This partnership model ensures that Sorting Robotics stays ahead of market trends while continuing to meet the evolving needs of cannabis manufacturers.
As Sorting Robotics solidifies its position as a leader in cannabis manufacturing, Partansky is already looking ahead. Jiko Robot and Stardust have set a high standard for automation, but for Partansky, these advancements are just the beginning. His next frontier? Quality control and end-of-line packaging—areas ripe for technological disruption.
"Quality control doesn't need to be done by humans," he says. "With a combination of robotic sensors and neural networks, we can simulate human judgment to ensure that every joint meets top-tier standards." Most quality checks in cannabis production are manual, relying on operators to spot flaws such as uneven packing, stems poking through pre-rolls or incorrect weights. Automating these checks would save time and improve consistency, ensuring that only flawless products reach consumers.
Partansky envisions a future where cannabis manufacturing mirrors the efficiency of a Coca-Cola bottling plant but with flexibility tailored to the industry's unique demands. "We're imagining a system where joints are scanned, categorized as ‘go' or ‘no-go,' and seamlessly packaged," he explains. "The variability in cannabis requires machines that can handle endless formats and specifications, unlike the standardized lines in food and beverage industries."
This adaptability is key, as cannabis manufacturing remains highly fragmented. "The industry hasn't matured to the point where we have just a few standard form factors," Partansky explains. "There are so many variations in cartridges, pre-rolls and edibles. Our machines need to be flexible enough to accommodate that."
Despite regulatory hurdles in emerging markets, Partansky is optimistic about the future of cannabis automation. Drawing parallels to the candy industry, he explains how products once dismissed as novelties became foundational. "Cannabis is following a similar trajectory. The products we think of as trends today are laying the foundation for tomorrow's market."
For Sorting Robotics, this means staying ahead of the curve by anticipating the needs of an evolving industry. "Our goal is to build tools that not only solve today's problems but also prepare businesses for what's next," says Partansky. "As the industry grows, so do the challenges—and we're here to solve them."
Images courtesy of Sorting Robotics.
Direxion CEO Douglas Yones shared some insights with Benzinga on how cryptocurrency and commodities could benefit from ongoing macroeconomic uncertainties.
Despite traditional markets facing instability, Yones is optimistic about cryptocurrency's continued rise — especially Bitcoin (CRYPTO: BTC).
In 2024, "the top three new ETFs by AUM in the U.S. were all Bitcoin-related, and we expect this trend to continue,” he says.
President-elect Donald Trump‘s pro-crypto administration is expected to play a role in fueling further demand for digital assets. ETFs such as the Direxion Daily Crypto Industry Bull 2X Shares (NYSE:LMBO) and the Direxion Daily Crypto Industry Bear 1X Shares (NYSE:REKT) could see increasing interest as investors seek growth in this space.
Read Also: Trump Could Sign Crypto-Related Executive Orders On Day 1: Report
Commodities are also expected to see heightened demand as a way to diversify portfolios beyond stocks and bonds.
"With U.S. equity valuations at lofty levels and inflation still persistent, commodities can potentially provide added diversification within an overall portfolio," Yones says.
The Direxion Auspice Broad Commodity Strategy ETF (NYSE:COM) is one such option.
Traders would be wise to look at leveraged and inverse ETFs, too.
"ETFs, particularly leveraged and inverse ones, offer a flexible way to navigate the ups and downs of the market,” Yones says.
These ETFs can provide both bullish and bearish exposure. This makes them ideal for those seeking to capitalize on short-term market movements.
Read Next:
Image: Shutterstock
Arthur Hayes, co-founder of cryptocurrency exchange BitMEX and Chief Investment Officer at Maelstrom Fund, stated that Bitcoin (CRYPTO: BTC) will thrive regardless of any government support or regulatory clarity under the incoming Donald Trump administration.
What Happened: In an interview with Benzinga, Hayes questioned the narrative that cryptocurrency-friendly regulations will serve as a bullish catalyst for the market
“Remember that we got to a total cryptocurrency market cap of over $3 trillion with no government support anywhere in the world. Why do we need it now?” Hayes argued.
As for Bitcoin, Hayes said that the leading cryptocurrency will flourish in spite of any regulations that would be enacted by Trump.
See Also: Shytoshi Kusama Outlines TREAT Token’s Usefulness Ahead Of Launch, Optimistic Whales Buy Up Shiba Inu
Hayes expressed doubt on potential cryptocurrency-friendly policies under Trump, saying that most of them will only benefit his lobbyists and close advisors.
“I fear that the crypto regulation that Trump enacts will be a Frankenstein bill that is an inchoate mishmash of different policies desired by this or that close advisor or large campaign donor,” he said.
“It will be a gift to lobbyists and lawyers and will not ultimately bring that much clarity, as it will be impossible to comply with unless you have hundreds of millions of dollars to spend on lawyers.”
Hayes has been a long-time Bitcoin bull, projecting the apex cryptocurrency to hit $1 million in the long term.
Why It Matters: Hayes’ remarks come at a time when the incoming Trump administration is expected to significantly alter the landscape of cryptocurrency regulation.
Recent reports suggested that Trump could issue executive orders on day one of his presidency, possibly addressing de-banking and fair value accounting, which requires banks holding cryptocurrencies to count them as liabilities on their balance sheet.
Trump has rewarded supporters with high-level appointments in the incoming administration. He named venture capitalist David Sacks, who held a fundraising event for Trump’s campaign at his home, as the “White House A.I. & Crypto Czar.”
Price Action: At the time of writing, Bitcoin was exchanging hands at $93,573.37, down 0.90% in the last 24 hours, according to data from Benzinga Pro.
Read Next:
As investors look to navigate the volatility of global markets in 2025, Direxion's CEO, Douglas Yones, sees the technology and energy sectors as key growth areas.
In an exclusive interview with Benzinga, he asserted that while broader market uncertainty persists, the semiconductor and energy industries are poised to stand out.
Yones points to the semiconductor industry, driven largely by the increasing demand for AI technology. "Technology, particularly the AI and semiconductor industries, stands out as a key area for growth," he shares.
As AI applications expand, the need for more advanced chips is set to rise, making this a high-potential sector. For traders looking to capitalize on this, Yones recommends leveraged ETFs such as the Direxion Daily Semiconductor Bull 3X Shares (NYSE:SOXL), which offer significant exposure to the semiconductor industry.
Read Also: Analyst Sees ‘Broadening Rally’ In Semiconductors In 2025: 2 Top Stock Picks, 2 To Avoid
The energy sector is also expected to thrive in 2025, with favorable policies likely to drive growth in fossil fuel companies. "The Trump administration has made its stance on drilling very clear, and the administration may be more friendly to fossil fuel companies," says Yones.
He believes this will likely hurt alternative energy stocks, but make energy ETFs like the Direxion Daily Energy Bull 2X Shares (NYSE:ERX) an appealing choice for traders.
With AI driving technological advances and President-elect Donald Trump‘s administration continuing its pro-fossil fuel stance, both semiconductors and energy stocks are expected to dominate investor portfolios in the year ahead.
"We expect energy and semiconductor stocks to benefit from both technology trends and government policies," Yones said.
Read Next:
Photo: Shutterstock
“I’ve always been an adventure seeker,” says Cort Smith.
Those words encapsulate the driving force behind a career that thrives on calculated risks and breakthrough developments. As the founder of Synergy Innovation, the parent company of DaVinci Vaporizers and Eyce, Smith has channeled his passion for precision and problem-solving into reshaping the cannabis accessories market. DaVinci's vaporizers have become synonymous with meticulous engineering for connoisseurs, while Eyce is renowned for its nearly indestructible gear, designed for the adventurous spirit. Together, these brands reflect Smith's commitment to blending innovation, functionality and durability.
Sitting down at MJBizCon in Las Vegas, Smith's energy is palpable as he recounts how his unconventional journey unfolded. From building bungee jumping equipment in China to creating one of the world's most trusted cannabis vaporizer brands, Smith’s story is one of bold decisions and unrelenting dedication to quality.
"I was in an economics class in the 80s," he begins, "and someone mentioned China. They said, ‘In the next 30 years, it's going to become one of the top five economies in the world.'" At a time when Japan dominated discussions of global opportunity, Smith saw potential elsewhere. "I thought, ‘I'm going to miss that boat,'" he told Benzinga, referencing Japan's popularity among aspiring entrepreneurs. "But no one was talking about China yet." Recognizing the untapped possibilities, Smith began learning Mandarin and preparing for a future in a country few Westerners dared to explore.
Smith's entrepreneurial debut was as unconventional as it was audacious: launching a bungee jumping business in China. "I was producing my own bungee cords, equipment and towers—all in China," he recalls. "I thought it'd be a one-or-two-year stepping stone to figure out what else a foreigner could do there."
But what started as a short-term venture quickly became a pivotal chapter in his life. "That business turned into a PhD-level education in negotiating with factories, contracting and building something where safety is critical," he says. Managing the intricacies of a high-risk operation in an unfamiliar market demanded precision, adaptability and resilience, skills that would later become hallmarks of Smith's approach to manufacturing.
After five years in the bungee business, Smith shifted gears, applying his expertise to a broader range of manufacturing projects. "Other people started coming to me, saying, ‘Hey, I want to build something,'" he says. From producing massive banners for NASCAR to managing custom projects, Smith honed his ability to guide complex manufacturing processes. "I realized how much detail was needed to babysit these processes."
This phase of his career ultimately introduced him to the burgeoning e-cigarette industry. While the work refined his design and manufacturing skills, Smith found little personal fulfillment in the sector. "I wasn't a tobacco guy," he admits. "I didn't get to control the product. It was just receiving goods from China and helping sell them."
The turning point came in 2011 when Smith envisioned a new direction: cannabis vaporizers. He recalls telling his partner, "You're building something with a battery that gets hot for human ingestion. Why don't we spin this for cannabis?" The concept resonated deeply and DaVinci Vaporizers was born.
Smith's personal experiences with cannabis fueled his drive to innovate. "I'd go to a buddy's house, crack a few beers, smoke a few bowls and end up with these terrible tension headaches," he says. A chance encounter with a vaporizer at a cannabis expo shifted his perspective. "It wasn't great, but I noticed I didn't get the same headaches. I thought, ‘I can build something better.'"
With DaVinci, Smith set out to create the cleanest, most reliable vaporizer on the market. "No lead soldering, no off-gassing from cheap plastics," he explains. His vision was simple yet ambitious: design a device that prioritized safety and performance above all. This philosophy laid the foundation for DaVinci's signature features, such as ceramic heating bowls that maintain stable temperatures for consistent, high-quality vapor.
The reputation of DaVinci Vaporizers isn't solely built on the quality of its devices. It's also shaped by Smith's deliberate global approach to the cannabis accessories market, a vision that extended well beyond North America. While many companies prioritized the domestic market, Smith recognized the potential of international opportunities early on. "We were early to go to the trade shows overseas and connect with international customers," he says, describing how these connections helped DaVinci gain traction across Europe and other regions.
Smith's appreciation for constant refinement found inspiration in an unlikely place: the workshops of Leonardo da Vinci himself. "I visited his old homes and saw his work firsthand," Smith shares. "It gave me the mindset to keep refining, to never stop improving." That relentless drive to perfect his craft resonated with a worldwide audience and helped cement DaVinci's reputation for reliability and innovation.
Unlike many cannabis brands that struggle to gain recognition outside their home markets, DaVinci stands out as a trusted name among cannabis enthusiasts globally. Similar to brands like RAW Rolling Papers and OCB Rolling Papers, DaVinci has achieved an exceptional level of recognition by maintaining its focus on high-quality vaporizers for discerning consumers. While Smith's scope remains focused on creating premium devices, DaVinci's ability to connect with a global audience is a testament to the brand's dedication to quality and precision.
Smith's drive for innovation doesn't stop with vaporizers. Under Synergy Innovation's umbrella is Eyce, a brand known for its rugged, high-performance smoking accessories that are nearly indestructible. "Eyce is the best in class for durability," Smith explains. Designed for an active lifestyle, Eyce products pair silicone exteriors with glass inserts, offering users the purity of glass combined with unmatched resilience.
Smith himself is a dedicated fan. "My daily go-to is an Eyce product," he says, noting the practicality of its design. "It's rugged enough that my dog can chew on it, or I can toss it in a backpack. It's a product that just works, no matter where you are." With its lifetime guarantee and appeal to adventurous users, Eyce has carved out its own niche in the cannabis accessories market, standing alongside DaVinci in customer loyalty and trust.
This dual-pronged approach – DaVinci for precision and sophistication and Eyce for durability and practicality – highlights Synergy Innovation's ability to cater to diverse consumer needs. "We're not trying to be everything to everyone," Smith explains. "We focus on building the best products for the people who care about quality, whether it's a rugged Eyce piece for the outdoors or a DaVinci vaporizer for precision enthusiasts."
Smith's commitment to quality extends far beyond his products; it's a cornerstone of the culture at Synergy Innovation. The company embodies a work-hard, play-hard ethos where team outings often double as creative brainstorming sessions. "We're in the green industry, so why not be edgy?" Smith says with a smile. "We don't follow the norms. We see our colleagues more than we see our families, so we try to make it feel like family."
This collaborative and adventurous spirit fuels creativity and ensures the products stay aligned with their mission of authenticity. For Smith, maintaining a sense of fun and passion is just as important as the technical precision that defines Synergy Innovation's products. "It's about more than just work," he says. "When you love what you do, it shows in the products you create."
Looking ahead, Smith is determined to continue innovating without compromising his values. With new products and technologies already in the pipeline, Synergy Innovation is set to build on the legacy of precision, durability and quality that DaVinci and Eyce have established. For Smith and his team, the mission is clear: create industry-leading products that elevate the cannabis experience for consumers worldwide.
Photos courtesy of Synergy Innovation
On Tuesday, Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) announced the development of a modular configuration for its VORTX blood oxygenation delivery technology.
As per the company website, the VORTX technology is designed to enrich small volumes of blood with oxygen and simultaneously remove carbon dioxide to elevate saturation levels to 95% or higher.
The VORTX aims to oxygenate blood without fiber membranes, which are known to cause harmful turbulence, friction, and shear forces, increasing damage to blood cells and clotting.
The modular configuration of the VORTX blood oxygenation delivery system is expected to extend the INSPIRA Augmented Respiration Technology’s (ART) range of blood oxygen enrichment and carbon dioxide removal.
The flagship INSPIRA ART system aims to revolutionize the $19 Billion Mechanical ventilation market and is being designed to elevate and stabilize declining oxygen saturation levels in patients while they are awake and without a ventilator.
The company adds that, unlike traditional fiber-based oxygenators, the VORTX is designed to maintain a more natural blood flow, potentially reducing harmful effects on blood components. Thirty-two novel patent claims protect the technology.
In September, Inspira secured an additional U.S. Patent approval for the VORTX orbiting blood oxygenation delivery system.
The technology can provide life-saving support for the approximately 20 million ICU patients with respiratory failure annually.
Recently, Inspira announced that it is preparing for a potential production ramp-up of its INSPIRA ART100 device in light of the recent human metapneumovirus (hMPV) outbreak in China.
Price Action: IINN stock is down 1.89% at $1.04 during the premarket session at last check Tuesday.
Read Next:
On Tuesday, Soligenix Inc. (NASDAQ:SNGX) announced an interim update on the open-label, investigator-initiated study (IIS) evaluating extended HyBryte (synthetic hypericin) treatment for up to 12 months in patients with early-stage cutaneous T-cell lymphoma (CTCL), a type of cancer that starts in the T-lymphocytes, a type of white blood cell that fights infection.
Cutaneous T-cell lymphoma is a group of rare blood cancers that affects the skin.
Nine patients have been enrolled and treated with HyBryte over up to 54 weeks.
Also Read: Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
Patients have responded positively to HyBryte therapy, with over 70% (5 of the 6 subjects who have completed at least 18 weeks of therapy) already achieving "Treatment Success."
Treatment Success is predefined in the study's protocol as a greater than or equal to 50% improvement in the cumulative mCAILS (modified Composite Assessment of Index Lesion Severity) score compared to the baseline.
Three of the five Treatment Successes were achieved within the first 12 weeks of treatment, with two patients achieving a "complete response" by 18 weeks.
Of the remaining patients, two have recently started the study, and two had to drop out for logistical reasons. One showed a substantial improvement (>30%) by their Week 18 visit. In addition, HyBryte appears to be safe and well-tolerated in all patients.
In December, Soligenix announced that patient enrollment had opened for its confirmatory Phase 3 study evaluating HyBryte (synthetic hypericin) for CTCL.
The confirmatory Phase 3 study, FLASH2, builds on the previous statistically significant Phase 3 (FLASH) study, as well as a recent comparative study (HPN-CTCL-04) and an ongoing investigator-initiated study, each further supporting the design of the FLASH2 clinical trial.
The active ingredient in HyBryte is synthetic hypericin, a potent photosensitizer that is topically applied to skin lesions that is taken up by the malignant T-cells, and then activated by safe, visible light approximately 24 hours later.
Price Action: SNGX stock closed at $3.13 on Monday.
Read Next:
"My first legal joint burned like hell. It was hot, the material was dried out, and it canoed," recalls Kyle Loucks, founder and CEO of RollPros, as he describes the experience that led to his work in the cannabis pre-roll space. For Loucks, that moment wasn't just a personal disappointment, it brought a major realization. What was supposed to be a magical milestone, celebrating legalization and quality craftsmanship, turned into an encounter with a product that fell far short of expectations. Instead of moving on, Loucks decided to do something about it.
Loucks’ first pre-roll was meant to be a celebration, a symbol of how far the industry had come. Instead, it exposed a persistent problem in the market. "I saw a problem," he says. "This is not my level of joint." For someone who had spent more than 20 years perfecting the art of rolling by hand, encountering such a poorly made product sparked an idea. Retreating to his garage, Loucks began working on a solution that could deliver consistent, high-quality joints at scale.
At the core of his solution is TruRoll technology, a proprietary system that flips the traditional cone-filling process on its side—literally. "We feed horizontally, so you can fill fresh, sticky weed with a big grind size. Then we roll it and tighten it as we go. It's just a better way to make a joint," Loucks explains.
The horizontal feeding approach addresses a common challenge with cones: their narrow aperture, which often leads to uneven packing and airflow issues. By rethinking the mechanics of rolling, Loucks developed a system that preserves the integrity of fresh flower while ensuring a consistent burn. His invention appeals not just to craft growers but also to larger operators looking for efficiency without sacrificing quality.
RollPros’ flagship product, the Blackbird Rolling System, is designed for cannabis enthusiasts who value both precision and consistency. It combines Loucks' hands-on experience with advanced automation to replicate the quality of hand-rolled joints on an industrial scale. "We've done over 80 million joints now and have about 160 machines out in the wild," Loucks shares, highlighting the growing demand for his technology.
The Blackbird's design focuses on preserving what makes a joint special. "I selfishly designed it for myself," Loucks says, emphasizing his personal standards as a cannabis connoisseur who values fresh flower and optimal burn quality. "I like a large grind size to keep all those flavonoids and terpenes on the plant," he adds. To complement this, RollPros sources high-quality paper from one of the oldest paper mills in France, ensuring an even, smooth burn.
Beyond quality, the Blackbird is also about flexibility. Operators can customize nearly every aspect of the rolling process, from density and draw resistance to the type of filter or paper used. "You can do big fatties, little pinners, ceramic tips, glass tips, wood tips—it's all customizable," Loucks explains. The machine's adaptability allows brands to tailor their products to meet the specific preferences of their customers, creating a unique identity in a competitive market.
For Loucks, the design of the Blackbird Rolling System was always rooted in serving the craft cannabis community, those who value quality and freshness over mass production. "It's really tailored for the craft grower," he explains. Inspired by the dedication of phenohunters and small-scale cultivators in places like the Emerald Triangle, Loucks wanted to create a tool that could seamlessly integrate into these operations while maintaining the standards of hand-rolled joints.
The Blackbird's compact size makes it an ideal fit for such setups. Measuring approximately four feet by two feet and standing about four feet tall, it's no larger than two college refrigerators placed side by side. "It's on casters, so you can roll it from room to room," Loucks adds.
However, the machine's utility doesn't stop at the craft level. The Blackbird has also gained traction among larger players in the cannabis industry, including multi-state operators (MSOs) looking for efficient and scalable solutions. "We've got all the way up to the big MSOs using our equipment," Loucks shares. "It's great to see the big guys starting to look at us and being like, ‘This is how you make a quality consumer experience.'"
Of course, innovation comes at a price. The Blackbird Rolling System is an investment, with a starting cost of approximately $250,000. For some operators, that might seem like a steep entry point, but Loucks points out that the machine's scalability and potential for high-volume output can make it a cost-effective choice in the long run. With the ability to produce roughly 900 joints per hour, the system can quickly pay for itself in the right hands.
Loucks recounts the story of a particularly resourceful customer who purchased a Blackbird and turned it into a mobile rolling service. "He had it in a trailer and would roll it onto farms to offer rolling as a service. Then he'd pack it back up and head to the next place," Loucks explains. This entrepreneurial approach not only provided immediate value to local growers but also allowed the customer to recoup his investment faster than expected.
For operators who may not have the upfront capital, RollPros offers leasing options to make the technology more accessible. This flexibility ensures that craft growers and boutique operations can still benefit from the Blackbird's capabilities without being priced out of the market.
While the Blackbird Rolling System has carved out a niche for itself in the cannabis pre-roll market, Loucks is already looking ahead to the next set of challenges facing the industry. "I think packaging is next," he says, pointing to sustainability as a critical area for improvement. The current options for pre-roll packaging often rely on single-use plastics or other environmentally unfriendly materials, a problem Loucks believes can be addressed with the same innovative mindset that brought TruRoll technology to life. "I want to find some more sustainable options for packaging, but I've got to do it with the same level of innovation that I did with the Blackbird."
Loucks' approach to problem-solving is rooted in collaboration. "I love to brainstorm," he shares. "Hit me up on LinkedIn, let's do a Zoom, I'll get the whiteboard out—tell me your problem." For Loucks, innovation doesn't happen in isolation. By inviting growers, operators and other industry professionals to share their pain points, he aims to create solutions that are not just technically sound but deeply aligned with the needs of the cannabis community.
Despite the technological sophistication of the Blackbird, Loucks is quick to acknowledge the irreplaceable value of the human touch in cannabis culture. For many enthusiasts, rolling a joint is as much about the ritual as it is about the final product. Loucks, a self-described "ritual guy," understands this intimately. "Rolling a joint is like making espresso," he says. "It's about the smell, the feel, the whole experience."
This perspective is woven into the very fabric of RollPros. While the Blackbird enables consistent, high-quality production at scale, it doesn't seek to replace the craft of rolling by hand. Instead, it provides a tool for those who want to take their craft to the next level, blending tradition with innovation. "The people that are really successful with our machine are joint rollers and joint smokers," Loucks explains. "They know what a good joint feels like, and they can dial in the machine to hit all those same parameters."
With more than 80 million joints produced and a growing roster of customers ranging from boutique craft growers to large-scale MSOs, RollPros is becoming a cornerstone of the cannabis pre-roll industry. Loucks credits much of this success to his ability to remain connected to the community he serves. Whether through brainstorming sessions, hands-on product development or simply sharing his passion for well-rolled joints, Loucks keeps his focus on the people who make the cannabis industry what it is.
As he reflects on his journey, Loucks remains energized by the challenges that lie ahead. "There are big problems all across the industry," he says. "And I'm here to help solve them."
Images courtesy of RollPros.
On Monday, Artelo Biosciences Inc (NASDAQ:ARTL) completed a safety review of the first cohort of eight healthy volunteers in the company's Phase 1 study of ART26.12.
ART26.12 is the lead compound in Artelo's proprietary Fatty Acid Binding Protein (FABP) platform and is believed to be the first-ever selective FABP5 inhibitor to enter clinical trials.
FABPs are a family of intracellular proteins that chaperone lipids essential to normal cellular function. FABP is overexpressed and associated with abnormal lipid signaling in several pathologies.
In development as a non-opioid approach to the management of painful neuropathies, ART26.12 has already demonstrated significant promise in multiple preclinical pain models, including chemotherapy-induced peripheral neuropathy, diabetic neuropathy, cancer bone pain, and osteoarthritis.
Based on the safety profile of ART26.12 in preclinical studies, the company looks forward to learning from the initial safety, pharmacokinetic, and biomarker data from this ongoing human study, which is expected to be completed during the first half of 2025.
With dosing already underway, the next cohort in the Phase 1 study will provide additional insight into the development.
Results from the current Phase 1 single ascending dose study are intended to determine the most suitable doses of ART26.12 to utilize in a multiple ascending dose study evaluating ART26.12 in healthy volunteers planned for the second half of 2025.
In December, Artelo Biosciences announced the presentation of preliminary data on ART27.13, a benzimidazole derivative being studied for cancer-related anorexia.
Artelo is evaluating ART27.13 in the Phase 1/2 trial in cancer-related anorexia, which is currently enrolling Phase 2 of the study.
In Phase 1, ART27.13 was orally administered at 150 to 650 microgram doses.
The investigational drug was well tolerated, with only mild to moderate adverse events observed in a minority of participants.
At one month of treatment, two-thirds of participants showed evidence that the drug was impacting their weight loss, with either stabilization or reversal of weight loss associated with their cancer.
Phase 2 is accruing participants at a 650 microgram dosage with planned escalation at 4-week intervals up to a dose of 1300 micrograms per day. The study is expected to complete enrollment during the first half of 2025.
Price Action: ARTL stock closed at $1.16 on Monday.
Read Next:
Quick Contact
Address
1 Campus Martius Detroit,
MI 48226, United States
Phone
Get in Touch
We love to help & we love to listen. Please fill out the form
below and we’ll get back to you within a day
Customer Support
© 2023 Benzinga APIs | All Rights Reserved
